CyberHeart Inc., a Menlo Park, Calif.-based developer of a non-invasive system to treat cardiac arrhythmias, has raised $9 million in Series A funding. Emergent Medical Ventures and United Investments (
CyberHeart Incorporated, a Menlo Park, Calif-based medical device company developing the first totally non-invasive system to treat cardiac arrhythmias, today announced the close of a $9 million Series A financing. The investment was co-led by Emergent Medical Ventures, LLP (
“We are pleased to have secured such knowledgeable and high caliber investors in this critical initial funding,” said Patrick Maguire, M.D., Ph.D., president and CEO of CyberHeart Incorporated.
CyberHeart plans to use the financing to fund the development of proprietary non-invasive technology for cardiac applications using the CyberKnife(